IT mistakes that can cripple a biotech startup

12/16/2012 | B2C Marketing Insider

Some biotechnology startups fail to make an adequate investment into their IT infrastructure, Steven Vigeant writes. "Running expensive scientific equipment on cheap infrastructure is a waste of resources and can cost you more in the long run." It's also important for biotechnology companies to understand the potential security risks that can come from using cloud technology, he notes.

View Full Article in:

B2C Marketing Insider

Published in Brief: